AAAAAA

   
Results: 1-17 |
Results: 17
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study
Authors: Papakostas, P Kouroussis, C Androulakis, N Samelis, G Aravantinos, G Kalbakis, K Sarra, E Souglakos, J Kakolyris, S Georgoulias, V
Citation: P. Papakostas et al., First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study, EUR J CANC, 37(15), 2001, pp. 1833-1838
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group
Authors: Pectasides, D Aravantinos, G Kalofonos, H Kiamouris, C Bafaloukos, D Xiros, N Nicolaides, C Visvikis, A Dimopoulos, MA
Citation: D. Pectasides et al., Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group, ANN ONCOL, 12(10), 2001, pp. 1417-1422
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer
Authors: Stathopoulos, GP Mavroudis, D Tsavaris, N Kouroussis, C Aravantinos, G Agelaki, S Kakolyris, S Rigatos, SK Karabekios, S Georgoulias, V
Citation: Gp. Stathopoulos et al., Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: A phase II study of the Greek Cooperative Group for Pancreatic Cancer, ANN ONCOL, 12(1), 2001, pp. 101-103
Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Papadimitriou, C Dafni, U Bafaloukos, D Skarlos, D Moulopouos, LA Razis, E Kalofonos, HP Aravantinos, G Briassoulis, E Papakostas, P Abela, K Gogas, E Kosmidis, P Pavlidis, N Dimopoulos, MA
Citation: G. Fountzilas et al., Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: A randomized study conducted by the Hellenic Cooperative Oncology Group, J CL ONCOL, 19(8), 2001, pp. 2232-2239
Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer
Authors: Fountzilas, G Papadimitriou, C Aravantinos, G Nicolaides, C Stathopoulos, G Bafaloukos, D Kalofonos, H Ekonomopoulos, T Skarlos, D Pavlidis, N Dimopoulos, AM
Citation: G. Fountzilas et al., Dose-dense sequential adjuvant chemotherapy with epirubicin, paclitaxel and CMF in high-risk breast cancer, ONCOL-BASEL, 60(3), 2001, pp. 214-220
Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status
Authors: Janinis, J Efstathiou, E Panopoulos, C Samantas, E Aravantinos, G Christodoulou, C Skarlos, D
Citation: J. Janinis et al., Phase II study of temozolomide in patients with relapsing high grade glioma and poor performance status, MED ONCOL, 17(2), 2000, pp. 106-110
Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma
Authors: Tsavaris, N Skarlos, D Bacoyiannis, C Aravantinos, G Kosmas, C Retalis, G Panopoulos, C Vadiaka, M Dimitrakopoulos, A Kostantinidis, K Mitropoulos, D Bougas, D Pantazopoulos, D Kosmidis, P
Citation: N. Tsavaris et al., Combined treatment with low-dose interferon plus vinblastine is associatedwith less toxicity than conventional interferon monotherapy in patients with metastatic renal cell carcinoma, J INTERF CY, 20(8), 2000, pp. 685-690
Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer
Authors: Aravantinos, G Dimopoulos, MA Kosmidis, P Bafaloukos, D Papadimitriou, C Kiamouris, C Pavlidis, N Sikiotis, K Papakostas, P Skarlos, DV
Citation: G. Aravantinos et al., Ifosfamide plus oral etoposide salvage chemotherapy for platinum-resistantpaclitaxel-pretreated ovarian cancer, ANN ONCOL, 11(5), 2000, pp. 607-612
Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study
Authors: Fountzilas, G Nicolaides, C Bafaloukos, D Kalogera-Fountzila, A Kalofonos, H Samelis, G Aravantinos, G Pavlidis, N
Citation: G. Fountzilas et al., Docetaxel and gemcitabine in anthracycline-resistant advanced breast cancer: A Hellenic cooperative oncology group phase II study, CANCER INV, 18(6), 2000, pp. 503-509
Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: Long-term results of a phase II multicenter study
Authors: Dimopoulos, MA Papadimitriou, CA Georgoulias, V Moulopoulos, LA Aravantinos, G Gika, D Karpathios, S Stamatelopoulos, S
Citation: Ma. Dimopoulos et al., Paclitaxel and cisplatin in advanced or recurrent carcinoma of the endometrium: Long-term results of a phase II multicenter study, GYNECOL ONC, 78(1), 2000, pp. 52-57
Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: The Hellenic Cooperative Oncology Group experience
Authors: Pectasides, D Economopoulos, T Kouvatseas, G Antoniou, A Zoumbos, Z Aravantinos, G Tsatalas, C Halikia, A Nikolaides, C Kiamouris, C Pappa, E Pavlidis, N Skarlos, D Fountzilas, G Dimopoulos, MA
Citation: D. Pectasides et al., Anthracycline-based chemotherapy of primary non-Hodgkin's lymphoma of the testis: The Hellenic Cooperative Oncology Group experience, ONCOL-BASEL, 58(4), 2000, pp. 286-292
Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group
Authors: Fountzilas, G Zisiadis, A Dafni, U Konstantaras, C Hatzitheoharis, G Papavramidis, S Bousoulegas, A Basdanis, G Giannoulis, E Dokmetzioglou, J Katsohis, C Nenopoulou, E Karvounis, N Briassoulis, E Aravantinos, G Kosmidis, P Skarlos, D Pavlidis, N
Citation: G. Fountzilas et al., Fluorouracil and leucovorin with or without interferon alfa-2a as adjuvanttreatment, in patients with high-risk colon cancer - A randomized phase III study conducted by the Hellenic Cooperative Oncology Group, ONCOL-BASEL, 58(3), 2000, pp. 227-236
Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy
Authors: Aravantinos, G Skarlos, DV Kosmidis, P Georgoulias, V Sgouros, I Bafaloukos, D Androulakis, N Florou, S Fountzilas, G
Citation: G. Aravantinos et al., Irinotecan (CPT-11) in patients with advanced colorectal cancer previouslytreated with 5-fluorouracil-based chemotherapy, CR R ONC H, 32(3), 1999, pp. 209-219
Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group
Authors: Dimopoulos, MA Bakoyannis, C Georgoulias, V Papadimitriou, C Moulopoulos, LA Deliveliotis, C Karayannis, A Varkarakis, I Aravantinos, G Zervas, A Pantazopoulos, D Fountzilas, G Bamias, A Kyriakakis, Z Anagnostopoulos, A Giannopoulos, A Kosmidis, P
Citation: Ma. Dimopoulos et al., Docetaxel and cisplatin combination chemotherapy in advanced carcinoma of the urothelium: A multicenter phase II study of the Hellenic Cooperative Oncology Group, ANN ONCOL, 10(11), 1999, pp. 1385-1388
Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study
Authors: Androulakis, N Kourousis, C Dimopoulos, MA Samelis, G Kakolyris, S Tsavaris, N Genatas, K Aravantinos, G Papadimitriou, C Karabekios, S Stathopoulos, GP Georgoulias, V
Citation: N. Androulakis et al., Treatment of pancreatic cancer with docetaxel and granulocyte colony-stimulating factor: A multicenter phase II study, J CL ONCOL, 17(6), 1999, pp. 1779-1785
Platinum-based chemotherapy of primary extragonadal germ cell tumours: TheHellenic Cooperative Oncology Group experience
Authors: Pectasides, D Aravantinos, G Visvikis, A Bakoyiannis, C Halikia, A Kalofonos, C Kosmidis, P Skarlos, D Fountzilas, G
Citation: D. Pectasides et al., Platinum-based chemotherapy of primary extragonadal germ cell tumours: TheHellenic Cooperative Oncology Group experience, ONCOL-BASEL, 57(1), 1999, pp. 1-9
Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group Study
Authors: Bafaloukos, D Aravantinos, G Samonis, G Katsifis, G Bakoyiannis, C Skarlos, D Kosmidis, P
Citation: D. Bafaloukos et al., Carboplatin, methotrexate and 5-fluorouracil in combination with medroxyprogesterone acetate (JMF-M) in the treatment of advanced or recurrent endometrial carcinoma: A Hellenic Cooperative Oncology Group Study, ONCOL-BASEL, 56(3), 1999, pp. 198-201
Risultati: 1-17 |